EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of P21-activated kinases 1 and 4 synergistically suppresses the growth of pancreatic cancer by stimulating anti-tumour immunity

Yi Ma, Chelsea Dumesny, Li Dong, Ching-Seng Ang, Khashayar Asadi, Yifan Zhan, Mehrdad Nikfarjam, Hong He

Cell Communication and Signaling · 2024

DOI: 10.1186/s12964-024-01670-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Communication and Signaling, 2024. Verfasst von Yi Ma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Austin Precinct, University of Melbourne, Level 8, Lance Townsend Building, Austin Hospital, 145 Studley Road, Heidelberg, VIC…. Hauptthemen laut MEDLINE: p21-Activated Kinases, Pancreatic Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MDHS, Austin Medical Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pancreatic ductal adenocarcinoma (PDA) is one of the most lethal types of cancer, and KRAS oncogene occurs in over 90% of cases. P21-activated kinases (PAK), containing six members (PAK1 to 6), function downstream of KRAS. PAK1 and PAK4 play important roles in carcinogenesis, but their combinational effect remains unknown. In this study, we have determined the effect of dual inhibition of PAK1 and PAK4 in PDA progression using knockout (KO) cancer cell lines.

Methods

Murine wild-type (WT) and PAK1KO pancreatic cancer cell lines were isolated from PAK1 +/+ and PAK1 −/− KPC ( LSL-Kras G12D/ + ; LSL-Trp53 R172H/ + ; Pdx-1-Cre ) mice. KPC PAK4KO and KPC PAK1&4 KO cell lines were generated from KPC WT and KPC PAK1KO cell lines respectively using the CRISPR-CAS9 gene knockout technique. PAK WT and KO cell lines were used in mouse models of pancreatic tumours. Cells and tumour tissue were also used in flow cytometry and proteomic studies. A human PDA tissue microarray was stained by immunohistochemistry.

Results

Double knock out of PAK1 and PAK4 caused complete regression of tumour in a syngeneic mouse model. PAK4KO inhibited tumour growth by stimulating a rapid increase of cytotoxic CD8+ T cell infiltration. PAK1KO synergistically with PAK4KO increased cytotoxic CD8+ T cell infiltration and stimulated a sustained infiltration of CD8+ T cells at a later phase to overcome the immune evasion in the PAK4KO tumour. The human PDA tissue microarray study showed the important role of PAK1 and PAK4 in intra-tumoral T-cell function.

Conclusion

Our results demonstrated that dual inhibition of PAK1 and PAK4 synergistically suppressed PDA progression by stimulating cytotoxic CD8 + T cell response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

p21-Activated KinasesPancreatic NeoplasmsAnimalsMiceCell Line, TumorHumansCell ProliferationCarcinoma, Pancreatic DuctalMice, Knockout

Stichwörter der Autor:innen

Intra-tumoral T cellsP21-activated kinases1&4Pancreatic ductal adenocarcinoma

Substanzen

p21-Activated KinasesPak1 protein, mousePak4 protein, mouse

Autor:innen und Institutionen

  • Department of Surgery, Austin Precinct, University of Melbourne, Level 8, Lance Townsend Building, Austin Hospital, 145 Studley Road, Heidelberg, VIC, Australia.
  • Department of General Surgery, Monash Health, Clayton, VIC, Australia.
  • Mass Spectrometry and Proteomics Facility, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, VIC, Australia.
  • Department of Anatomical Pathology, Austin Health, Heidelberg, VIC, Australia.
  • Drug Discovery, Shanghai Huaota Biopharm, Shanghai, China.
  • Department of Hepato-Pancreato-Biliary Surgery, Austin Health, Heidelberg, VIC, Australia.

Förderung

  • MDHS
  • Austin Medical Research Foundation

Zitieren

APA

Ma, Y., Dumesny, C., Dong, L., Ang, C. S., Asadi, K., Zhan, Y., Nikfarjam, M., & He, H. (2024). Inhibition of P21-activated kinases 1 and 4 synergistically suppresses the growth of pancreatic cancer by stimulating anti-tumour immunity. Cell Communication and Signaling. https://doi.org/10.1186/s12964-024-01670-2

Vancouver

Ma Y, Dumesny C, Dong L, Ang CS, Asadi K, Zhan Y, et al. Inhibition of P21-activated kinases 1 and 4 synergistically suppresses the growth of pancreatic cancer by stimulating anti-tumour immunity. Cell Communication and Signaling. 2024. doi:10.1186/s12964-024-01670-2

BibTeX
@article{Ma2024,
  author = {Ma, Yi and Dumesny, Chelsea and Dong, Li and Ang, Ching-Seng and Asadi, Khashayar and Zhan, Yifan and Nikfarjam, Mehrdad and He, Hong},
  title = {Inhibition of P21-activated kinases 1 and 4 synergistically suppresses the growth of pancreatic cancer by stimulating anti-tumour immunity},
  journal = {Cell Communication and Signaling},
  year = {2024},
  doi = {10.1186/s12964-024-01670-2}
}
Kostenlos starten →